IMPAIRMENT CHARGE INFORMATION

When preparing the standalone and consolidated interim reports for the first half of 2025, the company Polenergia S.A. (the”Issuer“) identified  impairment indicators and performed asset impairment tests. As a result of the above, on 4 August 2025, the Issuer’s Management Board decided to establish an asset impairment charge with respect to:

• the company Polenergia Fotowoltaika S.A. in the amount of ca. PLN 71 million;
• the company Polenergia H2HUB Nowa Sarzyna sp. z o.o. in the amount of ca. PLN 21 million.

The impairment charge is a non-cash one and its estimated impact on the Issuer’s consolidated performance before tax for 2025 is ca. PLN 92 million. It will be included in the Polenergia Group’s consolidated financial statements for the first half of 2025 under other operating expenses. It will be charged to operating profit/loss of the Polenergia Group, however, in line with the adopted definition, it shall not affect the EBITDA result. The amount of the impairment charge is an estimate and subject to change.

With regard to Polenergia Fotowoltaika S.A., the decision is a consequence of the market situation of the prosumer market and the prospects for further development of the industry, resulting in a clear failure by the company to meet its sales targets in the second quarter of 2025. Recently, there has been a significant slowdown in the market with respect to sales of solutions dedicated to prosumers, which has significantly reduced the profitability of the business.

With regard to Polenergia H2HUB Nowa Sarzyna sp. z o.o., the decision is related to the Issuer’s review of strategic options in the area of hydrogen operations which was announced by the Issuer in current reports No. 4/2024 of 8 February 2024 and 41/2024 of 14 August 2024. It is the outcome of the current assessment of the dynamics of the green hydrogen market and the project’s investment risk profile.

The above event is currently under review by the auditor and is subject to change.

Legal basis: Article 17(1) of the Regulation (EU) No. 596/2014 of the European Parliament and of the Council on market abuse and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC

Issuer’s Management Board